about
Cloning of a novel human RNA polymerase II subunit downregulated by doxorubicin: new potential mechanisms of drug related toxicityPharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicityCB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytesEffect of glutathione and N-acetylcysteine on in vitro and in vivo cardiac toxicity of doxorubicinPrevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the ratLong term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.Chronic vascular toxicity of doxorubicin in an organ-cultured arteryMarked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibitionE-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells.Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transporters.Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitroSynthesis of 3-[(N-carboalkoxy)ethylamino]-indazole-dione derivatives and their biological activities on human liver carbonyl reductase.Identifying Mazama gouazoubira (Artiodactyla; Cervidae) chromosomes involved in rearrangements induced by doxorubicinFluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors.Doxazolidine induction of apoptosis by a topoisomerase II independent mechanism.Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling LeukocytesDrug-induced pulmonary vascular disease--mechanisms and clinical patterns.Fluorescence depolarization measurements on oriented membranesPharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation.Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes.Cardiac troponins as biomarkers of drug- and toxin-induced cardiac toxicity and cardioprotection.Early identification of anthracycline cardiomyopathy: possibilities and implications.New drugs in respiratory disorders: II.A chemical perspective on the anthracycline antitumor antibioticsMultimodality imaging of tumor response to doxilThe marine metabolite SZ-685C induces apoptosis in primary human nonfunctioning pituitary adenoma cells by inhibition of the Akt pathway in vitroRole of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones.Cytolytic T lymphocytes and antibodies to myocytes in adriamycin-treated BALB/c mice. Evidence for immunity to drug-induced antigens.Ultrastructural alterations in the atrial myocardium of pigs with acute monensin toxicosis.Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer.The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenograftsEffects of cell density on drug-induced cell kill kinetics in vitro (inoculum effect).In vitro and in vivo immunosuppressive activity of a novel anthracycline, 13-deoxy, 5-iminodoxorubicin.Adriamycin cardiotoxicity monitoring by radionuclide scan.Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.Destruction of Leishmania mexicana amazonensis amastigotes within macrophages in culture by phenazine methosulfate and other electron carriers.Synergistic interaction between lipid-loading and doxorubicin exposure in Huh7 hepatoma cells results in enhanced cytotoxicity and cellular oxidative stress: implications for acute and chronic care of obese cancer patients.N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.Computational and experimental models of cancer cell response to fluid shear stress.
P2860
Q24321193-AACE9CC8-CCBE-4CB9-BC83-FA71FBF2CC31Q24648835-699BFE68-5FA2-47AF-90B9-8782216D22C7Q24649936-D0CF6C63-4BBE-4103-BF15-BD7E00E28392Q28328626-AFBFC146-BAC0-42EE-B1C8-E820A570222AQ28344693-98882496-EB09-44E9-974D-20B002FE3188Q28361151-13C8D5FB-7D34-490F-B5F9-8671BA80FBD2Q28361159-8A91E6FF-15BA-463C-BCCF-5CD906D41235Q28829301-DB2E4EB3-BD9B-43F2-BD52-23950397BB9CQ30543323-BB49854C-C21C-4E59-98BD-E98B144F8455Q33546112-1F0A2990-6707-480A-9C77-A00BE3F58E36Q33614685-D7B5E145-1CF9-4B9E-9694-DDBCA2556294Q33649972-CCA9B39E-D711-4EB1-A41A-65370E58CBB9Q33846726-E5801DEA-D222-4273-A088-6D9C74B9CC64Q34014165-A4C0C18E-6674-4FB0-97CD-FEB9F98E0CAAQ34056786-2FB2A3ED-AA11-4592-8118-DD1C1F24F12FQ34069596-7D4E8BE3-1957-4A46-8EEE-746F950EC9EBQ34194220-AC31235B-3581-4646-A709-58D84D0A04C2Q34260383-1EA2F8ED-B559-44C4-9235-D59ED92DE1ADQ34303346-529C8294-B397-41D8-BFC2-5C6477F3AFE8Q34361211-2AFB8BE3-57B2-483C-BF8A-9BD79CEEA737Q34550487-CCD1CBE6-72BC-4346-A27B-FE79671BD096Q34800157-F0AAFA8D-CB8F-4059-90EA-EAA95F4D15ACQ34991833-9A895B03-A060-44D8-ABA5-05A564A3C06FQ35035606-39E09C98-F038-4474-984D-D98C89801AE7Q35113876-7A2C5FAA-5FAD-4A88-ACCD-163D974A2F4DQ35228260-5750509B-D353-458B-AD01-AEB7D16CD26BQ35612344-4240EA1B-9CE4-4CE5-A071-F79F40126EA7Q35830962-84EAA1B3-60AF-4AF5-AFC6-3BA208542459Q35858117-852A3450-71E4-4800-931B-1A1B03725010Q35982550-72466AB3-98AA-4D15-B15E-5F5D6F7B63A4Q35992543-5233C518-0F99-47F1-A314-B93A32FF33A6Q35994638-59F8FB50-09F9-43C4-85AE-CDDACB79C92DQ36027786-C091A458-4057-469F-92A7-7DE5C5D7EA89Q36029934-2E3B51B0-C392-45EF-9E79-8DF7F4C582D1Q36047956-A4690E07-BA16-4376-BECC-019CD2895120Q36069595-45DEAB66-EAD5-4B40-A84F-B39A5294E9F3Q36346154-1C3A5C33-CCCD-4056-9A21-3015FCAE0533Q36407635-909812E5-CFF1-4FCA-B5D8-E9952EA48D8BQ36467867-10D3B8CE-4595-4657-9067-48B896E31C25Q36655350-81BCCB31-B09C-47E4-B1AD-CA70D3702221
P2860
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
The anthracycline antineoplastic drugs.
@en
type
label
The anthracycline antineoplastic drugs.
@en
prefLabel
The anthracycline antineoplastic drugs.
@en
P2093
P1476
The anthracycline antineoplastic drugs.
@en
P2093
P304
P356
10.1056/NEJM198107163050305
P407
P577
1981-07-01T00:00:00Z